Deregulation of COMMD1 is associated with poor prognosis in diffuse large B-cell lymphoma.
Despite improved survival for the patients with diffuse large B-cell lymphoma (DLBCL), the prognosis after relapse is poor. The aim was to identify molecular events that contribute to relapse and treatment resistance in DLBCL.We analysed 51 prospectively collected pretreatment tumour samples from cl...
Asıl Yazarlar: | , , , , , , , , , , , , , , , |
---|---|
Materyal Türü: | Makale |
Dil: | English |
Baskı/Yayın Bilgisi: |
Public Library of Science (PLoS)
2014-01-01
|
Seri Bilgileri: | PLoS ONE |
Online Erişim: | http://europepmc.org/articles/PMC3953211?pdf=render |